# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-01T00:23:56.243916
**Tokens:** 36972 in / 3431 out
**Response SHA256:** 24b28bb14a6b4ebf

---

I checked the draft carefully for the narrow set of FATAL errors you asked me to screen for (data-design alignment, blatant regression output anomalies, completeness, and internal consistency). I examined all reported tables, figures, sample definitions, treatment timing, panel/RDD design details, and appendix materials. Summary: I found no fatal errors.

Key checks I ran and results

1) Data–design alignment
- Treatment timing vs data coverage: Treatment in‑force dates (GR 2011, BE 2012, AG 2013, BL July 2016, BS Jan 2017) are all ≤ the latest referendum date used (May 21, 2017). Panel and cohort coding described in the text match the in‑force dates reported in Appendix Table 11. No instance where a canton is coded treated for a referendum that occurs before its in‑force date.
- Post-treatment observations: For the staggered DiD/Callaway–Sant’Anna and the DiDisc, there are post‑treatment referendums for the cohorts in question (2016 and/or 2017 depending on in‑force dates). The author documents excluding Basel‑Stadt from cohort-specific CSA inference (because its first post‑treatment period is the final period), and that exclusion is explicitly noted in the appendix—this is internally consistent.
- RDD data on both sides of cutoff: RDD sample construction is documented; municipalities on both sides of treated–control canton borders are present (counts NL, NR reported). Basel‑Stadt (surrounded by treated BL) is explicitly excluded from the RDD, consistent with the identification requirement.

2) Regression sanity
- Coefficients and standard errors: All reported coefficients and SEs are numerically plausible for percentage outcomes. No excessively large SEs, NaNs, negative SEs, or coefficients of implausible magnitude appear in any table. Reported Adj. R2 values are within [0,1]. Examples checked: Table 4, Table 5, Table 9, Appendix tables—numbers are consistent and reasonable.
- No impossible values (NA/Inf) in results tables.

3) Completeness
- No placeholder labels (TODO, XXX, NA) in tables or main reported regressions.
- Sample sizes (N) or effective sample counts are reported for main tables (e.g., Table 4 N=2,120; Table 5 NL/NR and total within bandwidth; Table 9 shows N). Standard errors / confidence intervals are provided for regressions.
- Robustness checks and diagnostics that are described (McCrary test, donut RDD, bandwidth sensitivity, permutation inference) are reported with results (figures/tables) or explicitly caveated when pre-correction samples are used. References to appendix tables/figures appear to correspond to existing appendix items.

4) Internal consistency
- Numbers in text match the numbers in the tables/figures I checked (e.g., same‑language RDD −5.9 pp, SE = 2.32 appears in Table 5 and is quoted in the text with the same CI; OLS language‑controls numbers in Table 4 match textual discussion).
- Treatment timing is used consistently across tables and figures (in‑force dates used throughout).
- Where the author excludes units (e.g., Basel‑Stadt from RDD or from cohort‑specific CSA inference), those exclusions are clearly described and consistently applied.

Minor points I noted (not fatal)
- The paper frequently contrasts "pre‑correction" and "corrected" RDD constructions; the author documents both and flags which figures use which construction. This is not a fatal inconsistency, but make sure the main text always indicates which construction a given figure/report uses (the draft mostly does this).
- Placebo RD tests use pre‑correction sample (the footnote clarifies this). Again not fatal, but keep that caveat prominent when interpreting placebo results.
- A few sample counts (e.g., N reported in Table 9 for DiDisc) are smaller than the theoretical maximum (municipalities × periods) because the sample is restricted; the manuscript explains these restrictions. This is consistent, not an error.

Conclusion
I did not find any FATAL errors in the four categories you asked me to screen for. The design and data coverage match the treatment timing; regression outputs are numerically sensible; required elements (Ns, SEs, CIs) are provided; internal numeric consistency holds across text/tables/figures.

ADVISOR VERDICT: PASS